From P-values to Patient Values:
MDIC to Reveal Patient-Generated P-Values from Parkinson’s Patient Preference Study
In September 2016, MDIC launched a new initiative in patient-centered clinical trials.
With CDRH, the Michael J. Fox Foundation for Parkinson’s Research, MIT, and RTI Health Solutions, we developed and tested a novel method for incorporating patient preference information as an explicit means to set significance levels in clinical trial design.
Setting patient- and therapy-specific significance levels may be a pathway to treatment access for patients with a higher risk tolerance and no effective therapies.
On May 18, 2018, at the Westin Arlington Gateway in Arlington, VA, we are pleased to present the results, implications, and next steps for this initiative. Download the agenda here.
Reports from the May 18 workshop
Workshop Summary: MDIC PCOR Project: From P-Values to Patient Values in Parkinson’s Disease
Guest article in Medical Device Online: The Science Of Patient Preferences In Med Device Clinical Trial Design
Slides and summaries from the May 18 workshop
- The MDIC PCOR project: Collaborating with industry, FDA and patients to create a new method for patient-centered clinical trials – Stephanie Christopher
- Keynote: Moving from P-Values to Patient values – Andrew Lo
- Keynote: A vision for partnering with patients – A conversation with the Michael J. Fox Foundation for Parkinson’s Research – Sohini Chowdhury
- Aim 2 breakout session – Designing and Conducting the Patient Preference Study
- Aim 3 breakout session – Designing methods for clinical trials based explicitly on patient input | Aim 3 Session Summary
Videos from the workshop
- Keynote: Moving from P-Values to Patient Values
- Keynote: A vision for partnering with patients – A conversation with the Michael J. Fox Foundation for Parkinson’s Research
- Aim 3 breakout session – Designing methods for clinical trials based explicitly on patient input
- Breakout session recap and closing panel- What are the implications of the patient-centered approach to clinical trials?
To learn more about the project visit our PCOR webpage or contact MDIC Science of Patient Input (SPI) Program Director, Liliana Rincon-Gonzalez at lrincon-gonzalez@mdic.org.